Virtus Family Office’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
64,401
+277
+0.4% +$7.38K 1.54% 19
2025
Q4
$1.6M Buy
64,124
+251
+0.4% +$6.33K 1.38% 26
2025
Q3
$1.63M Buy
63,873
+11,479
+22% +$283K 1.52% 24
2025
Q2
$1.27M Sell
52,394
-28,805
-35% -$672K 1.63% 27
2025
Q1
$2.06M Sell
81,199
-726
-0.9% -$19K 2.64% 16
2024
Q4
$2.17M Buy
81,925
+19,702
+32% +$534K 2.72% 14
2024
Q3
$1.8M Sell
62,223
-457
-0.7% -$13.3K 2.38% 19
2024
Q2
$1.75M Buy
62,680
+8,065
+15% +$222K 2.39% 20
2024
Q1
$1.52M Hold
54,615
2.42% 20
2023
Q4
$1.57M Buy
54,615
+9,363
+21% +$283K 2.63% 21
2023
Q3
$1.5M Buy
45,252
+10,342
+30% +$366K 2.73% 16
2023
Q2
$1.28M Buy
+34,910
New +$1.36M 2.37% 20
2022
Q4
Sell
-19,332
Closed -$846K 41
2022
Q3
$846K Buy
+19,332
New +$939K 2.16% 23

Other funds holding PFE

Virtus Family Office's PFE Position: Q1 2026 in Review

Virtus Family Office increased its Pfizer (PFE) stake by 0.43% in Q1 2026, buying an estimated $7.38K and bringing the position to 64,401 shares worth $1.81M. The position accounts for 1.54% of the portfolio, ranked #19.

Virtus Family Office first reported a position in PFE in Q3 2022 and has held it in 13 quarters since. The position peaked at $2.17M in Q4 2024. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Virtus Family Office held 64,401 shares of Pfizer worth $1.81M as of Q1 2026.
  • Virtus Family Office bought 277 Pfizer shares in Q1 2026, an estimated $7.38K.
  • Pfizer made up 1.54% of Virtus Family Office's portfolio in Q1 2026, its #19 holding.
  • Virtus Family Office first reported a position in Pfizer in Q3 2022 and has held it in 13 quarters since.
  • Virtus Family Office's Pfizer position peaked at $2.17M in Q4 2024.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Virtus Family Office's 13F filing for Q1 2026, filed 7 May 2026.